Luo Y - Search Results

1

Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.

Du F, Yuan P, Wang JY, Ma F, Fan Y, Luo Y, Xu BH. Du F, et al. Among authors: luo y. Asian Pac J Cancer Prev. 2015;16(3):903-7. doi: 10.7314/apjcp.2015.16.3.903. Asian Pac J Cancer Prev. 2015. PMID: 25735380 Free article.

2

[Long-term efficacy and safety of adjuvant trastuzumab for HER2-positive early breast cancer].

Luo Y, Zhang P, Fang LG, Dong M, Feng FY. Luo Y, et al. Zhonghua Yi Xue Za Zhi. 2013 Feb 19;93(7):504-7. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23660317 Chinese.

3

[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].

Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q. Li Q, et al. Among authors: luo y. Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23880002 Chinese.

4

[Clinical analysis of 34 patients with adrenal metastasis from breast cancer].

Li Q, Xu BH, Li Q, Zhang P, Yuan P, Wang JY, Ma F, Cai RG, Fan Y, Luo Y. Li Q, et al. Among authors: luo y. Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):855-7. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24447485 Chinese.

5

HER2 as a predictive factor for successful neoadjuvant anthracycline chemotherapy of locally advanced and early breast cancer.

Wang J, Xu B, Yuan P, Li Q, Zhang P, Cai R, Ma F, Fan Y, Luo Y. Wang J, et al. Among authors: luo y. Int J Biol Markers. 2014 Sep 30;29(3):e187-92. doi: 10.5301/jbm.5000094. Int J Biol Markers. 2014. PMID: 25041784 Free article. Clinical Trial.

6

Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.

Li Q, Liu M, Ma F, Luo Y, Cai R, Wang L, Xu N, Xu B. Li Q, et al. Among authors: luo y. PLoS One. 2014 Aug 19;9(8):e104870. doi: 10.1371/journal.pone.0104870. eCollection 2014. PLoS One. 2014. PMID: 25137071 Free PMC article.

7

[Clinicopathological features and prognosis of metastases to the breast from extramammary solid tumors].

Luo Y, Xu B, Li Q, Zhang P, Yuan P, Wang J, Ma F, Cai R, Fan Y. Luo Y, et al. Zhonghua Zhong Liu Za Zhi. 2014 Jun;36(6):453-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25241789 Chinese.

8

[Clinical analysis of 80 patients with combined small-cell lung cancer].

Luo Y, Hui Z, Yang L, Li J. Luo Y, et al. Zhongguo Fei Ai Za Zhi. 2015 Mar;18(3):161-6. doi: 10.3779/j.issn.1009-3419.2015.03.06. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25800573 Free PMC article. Chinese.

9

The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors.

Zhao J, Du F, Luo Y, Shen G, Zheng F, Xu B. Zhao J, et al. Among authors: luo y. Cancer Treat Rev. 2015 Jul;41(7):623-33. doi: 10.1016/j.ctrv.2015.05.004. Epub 2015 May 9. Cancer Treat Rev. 2015. PMID: 25981453 Review.

10

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial.

Wang J, Xu B, Yuan P, Ma F, Li Q, Zhang P, Cai R, Fan Y, Luo Y, Li Q. Wang J, et al. Among authors: luo y. Cancer. 2015 Oct 1;121(19):3412-21. doi: 10.1002/cncr.29492. Epub 2015 Jun 19. Cancer. 2015. PMID: 26096296 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,757 results

Search Page

Filters